REDWOOD CITY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that Russell Howard, Maxygen’s Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 8th Annual Healthcare Conference on Wednesday, November 8, at 2:30 p.m. ET at The Palace Hotel in New York City. Maxygen also announced that Stuart Pollard, Maxygen’s Chief Scientific Officer, will make a presentation, together with a co-presenter from Roche, regarding Maxygen’s Maxy-alpha program at the ThinkEquity ThinkTank Summit on Friday, November 10, at 9:20 a.m. ET at the Ritz Carlton Hotel in New York City. Both presentations will be webcast and can be accessed by visiting the investor relations section of Maxygen’s website at www.maxygen.com .
The presentations may include discussion of non-GAAP financial measures. Reconciliation of the non-GAAP financial measures to the most directly applicable GAAP measures can be found at www.maxygen.com under the “News-Financial Reconciliations” tab.
Maxygen, Inc., headquartered in Redwood City, California, is committed to the discovery, development and commercialization of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. For additional information on Maxygen, including access to Maxygen’s SEC filings, please visit Maxygen’s website at www.maxygen.com .
Maxygen, Inc.
CONTACT: Linda Chrisman of Maxygen, Inc., +1-650-298-5351
Web site: http://www.maxygen.com//
